6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Name: 6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients
SKU: 25226
Price: 30.00 USD
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 52 No. 2 Articles 2022 Tags: antipsychotic drugs, bipolar-disorder, Camilla Callegari, CRP, ERS, Franca Marino, inflammation, Marco Cosentino, Marco Ferrari, Marco Godio

Description

Description

Original Research

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

By Marco Ferrari, Marco Godio, Camilla Callegari, Marco Cosentino, Franca Marino

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Description

Original Research

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

M.E. Ceylan, MD: Pulmonary Hypertension During Lithium Therapy: Clinical Case Study

Zonisamide for Bipolar Depression by Deborah Dauphinais

Ian Jones, MRCPsych, PhD: Searching for the Puerperal Trigger: Molecular Genetic Studies of Bipolar Affective Puerperal Psychosis

6 Weeks Monotherapy with Antipsychotic Drug Reduced Inflammatory Markers in Bipolar Disorder Patients

Description

Original Research

Related products

Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening

M.E. Ceylan, MD: Pulmonary Hypertension During Lithium Therapy: Clinical Case Study

Zonisamide for Bipolar Depression by Deborah Dauphinais

Ian Jones, MRCPsych, PhD: Searching for the Puerperal Trigger: Molecular Genetic Studies of Bipolar Affective Puerperal Psychosis